首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Multiple sclerosis journal-experimental translational and clinical

缩写:

ISSN:N/A

e-ISSN:2055-2173

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引623
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ángel Pérez-Sempere,Elena García-Arcelay,Jacobo Caruncho et al. Ángel Pérez-Sempere et al.
This study evaluated perceived workplace difficulties in 128 individuals with early-stage relapsing-remitting multiple sclerosis and low physical disability. Significant workplace challenges were reported by 40.6% of participants. External ...
María Laura Facio,Marcelo Garcia,Benjamín Baraκian et al. María Laura Facio et al.
Background: Nearly 85% of patients with Multiple Sclerosis (MS) present oligoclonal bands (OB) by isoelectric focusing (IEF) in their cerebrospinal fluid (CSF). Currently, it is proposed to quantify free light chains (FLC...
Olivia Kalau,Poljanka Johnson,Jiwon Oh et al. Olivia Kalau et al.
Background: Cognitive impairment (CI) is a common feature of multiple sclerosis (MS). Radiologically isolated syndrome (RIS) can demonstrate CI patterns similar to MS, providing an opportunity to explore the associations ...
Lisa G Schoof,Laura Hogenboom,Zoé LE van Kempen et al. Lisa G Schoof et al.
Background: Infusion-related reactions (IRRs) are a common side-effect of ocrelizumab (OCR), with the highest risk occurring during treatment initiation. To minimize IRR risk, the first dose is split into two 300 mg infus...
Nour Farah,Simon Charbonneau,Sarah A Morrow et al. Nour Farah et al.
Background: Interpretation of cognitive impairment (CI) in persons with multiple sclerosis (PwMS) is limited by discrepancies between objective and subjective evaluation. ...
Amber Salter,Mudita Sharma,Gary R Cutter et al. Amber Salter et al.
Background: Men with multiple sclerosis (MwMS) experience distinct health, symptoms, and disease progression patterns compared to women, necessitating targeted research and clinical approaches. ...
Daniel R Orme,Eric Matesen,Devon Conway et al. Daniel R Orme et al.
Background: Relapse prevention in multiple sclerosis (MS) is accomplished with disease-modifying therapy (DMT). Relapse rates typically decrease with age while DMT-associated risks increase, complicating treatment of olde...
Cecilie Fjeldstad Pardo,Gerardo Fernandez,Bujana Allushi et al. Cecilie Fjeldstad Pardo et al.
Background: Cognitive dysfunction involving working memory is common in multiple sclerosis (MS) but is often under-detected in clinical assessments. Noninvasive digital biomarkers like oculomotor metrics may enhance the d...